Mendelian randomization analyses for the relevance of anti-H. pylori IgG seropositivity with risk of CHD. by Jing Wang (6206297)

Subjects:

Characteristics of HACE respondents by year. by David Henderson (4612354)

Subjects:

Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Three essential assumptions of the Mendelian randomization study. by Jing Wang (6206297)

Subjects:

Mendelian randomization analysis of the effect of anti-H. pylori IgG seropositivity on coronary heart disease (CHD). by Jing Wang (6206297)

Subjects:

Results data from this Mendelian randomization study. by Jing Wang (6206297)

Subjects:

Percentage of positive responses to overall satisfaction 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Subjects:

Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of mean days of wound healing across different wound types for wounds healed in more than 3 months durations (2022 and 2023). by Heba Tallah Mohammed (2822432)

Subjects:

Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for overall satisfaction between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues... by David Henderson (4612354)

Subjects:

Key characteristics of non-healed PI at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Associations of anti-H. pylori IgG seropositivity with mediators. by Jing Wang (6206297)

Subjects:

Comparison of mean days of wound healing across different wound types by healing durations in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of mean days of wound healing across different wound types for wounds healed in less than 3 months durations (2022 and 2023). by Heba Tallah Mohammed (2822432)

Subjects:

Proportion of healed wounds by healing duration in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Percentage of positive responses to access question 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Subjects:

Depletion of viral UL87 LTF in late infection does not affect viral long promoter transcription. by Qiaolin Hu (8677473)

Fig 3 - by Aihong Zheng (20571034)

Subjects:

Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC. by Aihong Zheng (20571034)

Subjects: